✦ LIBER ✦

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

✍ Scribed by Suda, Kenichi; Mizuuchi, Hiroshi; Murakami, Isao; Uramoto, Hidetaka; Tanaka, Fumihiro; Sato, Katsuaki; Takemoto, Toshiki; Iwasaki, Takuya; Sekido, Yoshitaka; Yatabe, Yasushi; Mitsudomi, Tetsuya

Book ID: 124115553
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 157 KB
Volume: 85
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2014.05.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired resistance mechanisms to tyrosi

Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny

✍ Suda, Kenichi; Mizuuchi, Hiroshi; Maehara, Yoshihiko; Mitsudomi, Tetsuya 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 398 KB

Mechanisms of Acquired Resistance to Epi

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

✍ Engelman, J. A.; Janne, P. A. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

Management of acquired resistance to epi

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer

✍ Sacher, Adrian G.; Jänne, Pasi A.; Oxnard, Geoffrey R. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

KRAS Mutation Is an Important Predictor

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer

✍ Massarelli, E.; Varella-Garcia, M.; Tang, X.; Xavier, A. C.; Ozburn, N. C.; Liu, 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 196 KB

Acquired resistance to epidermal growth

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins

✍ Remon, J.; Morán, T.; Majem, M.; Reguart, N.; Dalmau, E.; Márquez-Medina, D.; Li 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Clinical Significance of Heterogeneity i

Clinical Significance of Heterogeneity in Response to Retreatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Cancer Acquiring Secondary Resistance to the Drug

✍ Lee, Youngjoo; Kim, Hyae Young; Lee, Soo-Hyun; Lim, Kun Young; Lee, Geon Kook; Y 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 764 KB